FDA Inspection 1064475 — Sentara Infusion Services
The FDA completed an inspection of Sentara Infusion Services on August 6, 2018 in Chesapeake, VA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- August 6, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Chesapeake, VA (United States)